Regulon

Regulon: R-842

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
12-0.64684810Pr-122Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
3674 ENSG00000005961 ITGA2B P08514
26998 ENSG00000090512 FETUB Q9UGM5
1053 ENSG00000092067 CEBPE Q15744
959 ENSG00000102245 CD40LG P29965
2250 ENSG00000138675 FGF5 P12034
939 ENSG00000139193 CD27 P26842
2264 ENSG00000160867 FGFR4 P22455
5731 ENSG00000160951 PTGER1 P34995
2672 ENSG00000162676 GFI1 Q99684
253512 ENSG00000174032 SLC25A30 Q5SVS4
2300 ENSG00000176678 FOXL1 Q12952
6693 ENSG00000197471 SPN P16150

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
ALPROSTADILPTGER2Small moleculeAGONISTProstanoid EP1 receptor agonist40
BRIVANIB ALANINATEKDRSmall moleculeINHIBITORVascular endothelial growth factor receptor inhibitor30
ERDAFITINIBFGFR3Small moleculeINHIBITORFibroblast growth factor receptor inhibitor40
DAPIROLIZUMAB PEGOLCD40LGAntibodyINHIBITORCD40 ligand inhibitor30
DINOPROSTONEPTGER1Small moleculeAGONISTProstaglandin E2 receptor agonist40
FGF401FGFR4Small moleculeINHIBITORFibroblast growth factor receptor 4 inhibitor20
AT-1501CD40LGUnknownINHIBITORCD40 ligand inhibitor20
RUPLIZUMABCD40LGAntibodyINHIBITORCD40 ligand inhibitor30
BRIVANIBFGFR3Small moleculeINHIBITORFibroblast growth factor receptor inhibitor30
NINTEDANIB ESYLATEFGFR3Small moleculeINHIBITORFibroblast growth factor receptor inhibitor40
XL-999PDGFRBSmall moleculeINHIBITORFibroblast growth factor receptor inhibitor20
TIROFIBAN HYDROCHLORIDEITGB3Small moleculeINHIBITORIntegrin alpha-IIb/beta-3 inhibitor40
RAVAGALIMABCD40LGAntibodyANTAGONISTCD40 ligand antagonist20
ROGARATINIBFGFR3Small moleculeINHIBITORFibroblast growth factor receptor inhibitor20
AZD-4547FGFR3Small moleculeINHIBITORFibroblast growth factor receptor inhibitor20
ABCIXIMABITGB3AntibodyINHIBITORIntegrin alpha-V/beta-3 inhibitor40
INFIGRATINIBFGFR3Small moleculeINHIBITORFibroblast growth factor receptor inhibitor42
INFIGRATINIB PHOSPHATEFGFR3Small moleculeINHIBITORFibroblast growth factor receptor inhibitor40
NINTEDANIBFGFR3Small moleculeINHIBITORFibroblast growth factor receptor inhibitor42
FUTIBATINIBFGFR3Small moleculeINHIBITORFibroblast growth factor receptor inhibitor30
ORANTINIBPDGFRBSmall moleculeINHIBITORFibroblast growth factor receptor inhibitor30
VARLILUMABCD27AntibodyAGONISTCD27 antigen agonist22
ONO-8539PTGER1Small moleculeANTAGONISTProstanoid EP1 receptor antagonist20
DAZODALIBEPCD40LGProteinANTAGONISTCD40 ligand antagonist20
DERAZANTINIBFGFR3Small moleculeINHIBITORFibroblast growth factor receptor inhibitor20
EPTIFIBATIDEITGB3ProteinINHIBITORIntegrin alpha-IIb/beta-3 inhibitor40
ENMD-981693PDGFRBSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor20
TIROFIBANITGB3Small moleculeINHIBITORIntegrin alpha-IIb/beta-3 inhibitor40

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-842

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs